Therefore, we decided to study the GBP1 protein expression and its clinicopathological correlation in a series of prostate cancer samples, and then further explore its molecular biological consequences by performing GBP1 gene knockout (KO) in prostate cancer cell lines DU145 and PC3. The gene discussed is GBP1; the disease is prostate cancer.